Tanguler Tolga's Form 4 filing
Alnylam Pharmaceuticals, Inc. (ALNY) · filed Aug 19, 2025
- Accession no.
- 0001735276-25-000091
- Filed
- Aug 19, 2025
- Trade date
- Aug 15-18, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 9 non-derivative transactions. Open-market sales total $632.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tanguler TolgaCIK 0001849458 | Officer (EVP, Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2025 | Common Stock | AGrant or awardAcquired | +2,851 | $0.00 | $0 | 30,862 | Direct | |
| Aug 18, 2025 | Common Stock | SSaleDisposed | −39 | $447.98 | −$17,471.22 | 30,823 | Direct | |
| Aug 18, 2025 | Common Stock | SSaleDisposed | −90 | $449.92 | −$40,492.8 | 30,733 | Direct | |
| Aug 18, 2025 | Common Stock | SSaleDisposed | −39 | $450.92 | −$17,585.88 | 30,694 | Direct | |
| Aug 18, 2025 | Common Stock | SSaleDisposed | −103 | $451.99 | −$46,554.97 | 30,591 | Direct | |
| Aug 18, 2025 | Common Stock | SSaleDisposed | −329 | $452.96 | −$149,023.84 | 30,262 | Direct | |
| Aug 18, 2025 | Common Stock | SSaleDisposed | −543 | $454.04 | −$246,543.72 | 29,719 | Direct | |
| Aug 18, 2025 | Common Stock | SSaleDisposed | −241 | $454.84 | −$109,616.44 | 29,478 | Direct | |
| Aug 18, 2025 | Common Stock | SSaleDisposed | −12 | $455.82 | −$5,469.84 | 29,466 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.